Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B
- J. Hepatol., Jul 05 2024, S0168-8278(24)02333-X | https://doi.org/10.1016/j.jhep.2024.06.027